Therefore, they are nowadays recommended as first line therapy in patients with T2DM and atherosclerotic cardiovascular disease to reduce events, regardless of baseline or target HbA1c and concomitant glucose-lowering medication according to the 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes [31]
OSA and the obesity gap According to the World Health Organization, adult obesity is defined by a BMI of 30 or higher
How Does Retatrutide Compare in Cost to Other Research Compounds As of 2026, retatrutide remains in clinical development and is not commercially approved
There was also a study published last Saturday that demonstrated myo-inositols effectiveness in reducing gonadotropins and reducing the length of controlled ovarian hyperstimulation in women undergoing IVF
Because it strongly affects glucose regulation, combining it with certain drugs, foods, or supplements can raise the risk of hypoglycemia or worsen side effects